10x Genomics Inc. (TXG)
NASDAQ · Healthcare
10x Genomics Inc. Cash on Hand 2017–2025
10x Genomics Inc. annual cash on hand history from 2018 to 2024. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- 10x Genomics Inc. cash on hand as of December 31, 2024: 344.1M, a 4.24% decrease year-over-year.
- 10x Genomics Inc. cash on hand for 2024 were 344.1M, a 4.24% decrease from 2023.
- 10x Genomics Inc. cash on hand for 2023 were 359.3M, a 63.50% increase from 2022.
- 10x Genomics Inc. cash on hand for 2022 were 219.7M, a 62.59% decrease from 2021.
- 10x Genomics Inc. cash on hand for 2021 were 587.4M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| 10x Genomics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2024 | $344 |
| 2023 | $359 |
| 2022 | $220 |
| 2021 | $587 |
| 2020 | $664 |
| 2019 | $424 |
| 2018 | $65 |
10x Genomics Inc. Cash on Hand — FAQ
10x Genomics Inc. (TXG) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TXG's cash on hand history?
The chart and table above show 10x Genomics Inc.'s cash on hand by year and by quarter, including the growth rate.